Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy

Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy

Fluorine-18 Fluorodeoxyglucose (F-18 FDG) PET/CT is established as a powerful imaging tool for cancer detection and monitoring response to therapy. Sodium Fluorine-18 (F-18) was used in the 1970s for bone scanning and can be used as a skeletal tracer in current PET/CT scanners. The combined administration of F-18 and F-18 FDG in a single PET/CT scan for cancer detection was not attempted to date. We hope to learn what is the best approach for detection of cancer and thus to improve cancer treatment.

Inclusion Criteria:

• Patients older than 18-year-old, diagnosed with cancer
• Patients must understand and voluntarily sign an Informed Consent form after the contents have been fully explained to them

Exclusion Criteria:

• Patients who cannot complete a PET/CT scan
• Pregnant women
• Healthy volunteers
• Patients participating in other research studies

The subjects will not be paid to participate in this protocol. No costs will be charged to the subjects.